GE HealthCare's first quarter 2026 revenue of $5.1B beat estimates, but the company lowered its full-year profit outlook.

GE HealthCare reported first quarter 2026 revenue of $5.13 billion and adjusted EPS of $0.99. While revenue exceeded analyst expectations of $5.05 billion, adjusted EPS fell short of the $1.07 consensus estimate. The company lowered its full-year 2026 guidance for profit and free cash flow, citing increased inflationary pressures.

Key Highlights

• Organic revenue grew 2.9%, driven by strength in the Pharmaceutical Diagnostics segment, which saw revenues increase 21.7% to $770 million.
• Adjusted EBIT margin declined 150 basis points year-over-year to 13.5%, impacted by a supplier issue, tariffs, and an 8.1% organic revenue decline in the Patient Care Solutions segment.
• The company lowered its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from the previous range of $4.95 to $5.15, due to higher-than-expected inflation.